Overlook the Infraction or Stick to the Rules? Custom Case Solution & Analysis

Evidence Brief

Financial Metrics

Individual Performance: Marcus is the top-performing sales representative at Global BioPharma, consistently exceeding targets by 20 percent or more.
Contract Value: The specific deal in question is valued at 12 million dollars in annual recurring revenue.
Infraction Amount: Marcus charged 15,000 dollars to a personal credit card for a client dinner to bypass the corporate card limit and secure the contract.
Market Context: The company operates in a low-growth environment where a 12 million dollar loss would represent a 4 percent hit to regional revenue projections.

Operational Facts

Corporate Policy: Section 4.2 of the Employee Handbook mandates the use of corporate cards for all business expenses exceeding 500 dollars.
Zero Tolerance Clause: The policy states that any intentional bypass of financial controls is grounds for immediate termination.
Reporting Structure: Sarah reports to the Chief Operating Officer; Marcus reports directly to Sarah.
Audit Trigger: The infraction was flagged during a routine quarterly compliance audit by the finance department.

Stakeholder Positions

Sarah (VP of Sales): Values Marcus for his revenue generation but fears that ignoring the infraction undermines her authority and the compliance culture.
Marcus (Sales Representative): Admits to the action but views it as a necessary tactical move to win the business. He believes his performance should grant him some latitude.
Anthony (HR Director): Advocates for immediate termination to maintain the integrity of the zero tolerance policy and prevent legal liability for inconsistent enforcement.
The Client: Has a personal relationship with Marcus; the contract is contingent on Marcus remaining the primary account lead.

Information Gaps

Precedent: The case does not specify if other employees have been fired for similar non-fraudulent expense violations.
Legal Review: There is no data on the legal strength of the zero tolerance clause in the specific jurisdiction of the regional office.
Replacement Cost: The time and cost required to hire and train a sales lead of Marcus’s caliber are not quantified.

Strategic Analysis

Core Strategic Question

Does Global BioPharma prioritize a rigid rules-based culture to minimize regulatory and legal risk, or a results-based culture to maximize market share and revenue?

Structural Analysis

Value Chain Analysis: The Human Resource Management function is currently in direct conflict with Sales and Marketing. If HR enforces the termination, it destroys the primary value-generating activity (Sales) for the current fiscal year.
Agency Theory: Marcus has acted as a rogue agent, prioritizing his personal commission and the company’s revenue over the principal’s (the company) established risk-mitigation protocols. This creates an internal control failure that transcends the 15,000 dollar expense.
Competitive Advantage: The company’s advantage is tied to individual talent rather than proprietary systems. Firing Marcus cedes this advantage to competitors who may have more flexible compliance frameworks.

Strategic Options

Option 1: Strict Enforcement (Termination)

Rationale: Preserves the sanctity of the compliance framework and prevents a culture of exceptionalism.
Trade-offs: Immediate loss of 12 million dollars in revenue and high risk of Marcus taking the client to a competitor.
Resource Requirements: Legal team for termination, HR for immediate backfill recruitment.

Option 2: Conditional Retention (Sanction and Probation)

Rationale: Penalizes the behavior without destroying the revenue stream.
Trade-offs: Creates a precedent that rules are negotiable for high earners; potential friction with HR.
Resource Requirements: Sarah’s time for intensive monitoring and a revised compensation structure to claw back the 15,000 dollars.

Option 3: Policy Evolution

Rationale: Recognizes that the 500 dollar limit is an operational bottleneck that forced the infraction.
Trade-offs: Appears as a reactive move to protect a high performer; does not address Marcus’s intentional bypass.
Resource Requirements: Finance and Legal review to update the handbook.

Preliminary Recommendation

Pursue Option 2. Termination is a disproportionate response to an infraction that involved no fraud or theft of funds. Marcus did not steal; he used personal capital to facilitate a company win. However, the bypass of controls must be punished to maintain organizational discipline. A formal final warning combined with a total loss of bonus for the current quarter balances the need for rule enforcement with the reality of revenue requirements.

Implementation Roadmap

Critical Path

Day 1-5: Conduct a formal disciplinary hearing with Sarah, Marcus, and Anthony. Document the intentional nature of the bypass.
Day 6-10: Issue a written final warning. Announce the forfeiture of Marcus’s quarterly bonus.
Day 11-20: Sarah must meet with the 12 million dollar client to solidify the relationship, ensuring the company—not just Marcus—is the primary partner.
Day 30-60: Finance department must review and increase the 500 dollar limit for senior sales staff to 5,000 dollars to remove the incentive for future bypasses.

Key Constraints

HR Rigidity: Anthony may view anything less than termination as a failure of his department. Sarah must secure COO backing before the disciplinary hearing.
Talent Flight: Marcus may feel insulted by the bonus forfeiture and seek employment elsewhere. The 12 million dollar contract must be tied to a multi-year vesting incentive.

Risk-Adjusted Implementation Strategy

The primary risk is a wrongful termination suit or an inconsistent application claim from other employees. To mitigate this, the company must clearly distinguish between fraud (stealing money) and procedural bypass (using the wrong card). The implementation focuses on fixing the broken policy while maintaining the penalty for the individual. If Marcus rejects the probation, the company must be prepared to lose the 12 million dollars, as keeping him without any penalty is a terminal risk to corporate governance.

Executive Review and BLUF

BLUF

Retain Marcus. Penalize him. Global BioPharma cannot afford to lose 12 million dollars in revenue over a procedural infraction that involved no embezzlement or ethical breach toward patients. Firing a top performer for using a personal card to close a deal is a failure of management, not a triumph of ethics. Apply a heavy financial penalty to Marcus to signal that rules matter, then immediately raise the outdated 500 dollar expense limit that created this friction. Protect the revenue while modernizing the controls.

Dangerous Assumption

The most dangerous assumption is that firing Marcus will improve the company culture. In reality, terminating a high performer for a non-fraudulent technicality will likely trigger a talent exodus and encourage remaining staff to hide operational workarounds rather than reporting them.

Unaddressed Risks

Regulatory Scrutiny: While this is an internal expense issue, if the 15,000 dollars was used for improper payments to physicians, the company faces massive legal exposure. Probability: Low; Consequence: Catastrophic.
Internal Equity: Lower-performing employees who were fired for minor infractions may sue for discrimination if Marcus is spared. Probability: Moderate; Consequence: Moderate financial settlement.

Unconsidered Alternative

The team failed to consider a mandatory rotation. Move Marcus to a different territory or account for six months. This tests the stickiness of the 12 million dollar contract without Marcus’s direct presence and signals to the organization that no one is indispensable, all while keeping his talent within the firm.